Ex Parte LI et al - Page 2



              Appeal No. 2003-1020                                                                  Page 2                 
              Application No. 08/859,051                                                                                   
                     wherein said formulation delivers said active ingredient directly and selectively                     
              specifically to the cells of the hair follicle and to the hair shaft itself and does not deliver             
              said active ingredient generally to the dermis or circulation.                                               
                     122.  A formulation of liposomes containing at least one active ingredient that is                    
              effective in treating androgenic alopecia selected from the group consisting of                              
                     (a) an antisense nucleic acid molecule;                                                               
                     (b) an expression system therefor that hybridizes to an androgen receptor gene                        
              so as to inhibit androgen receptor expression; and                                                           
                     (c) an antiandrogen and                                                                               
                     said active ingredient encapsulated in said liposomes and said formulation free                       
              of unencapsulated active ingredient.                                                                         
                                                                                                                          
                     The references relied on by the examiner are:                                                         
              Bonte et al. (Bonte)                       5,384,126                    Jan. 24, 1995                        
              Roy et al. (Roy)                           5,556,956                    Sep. 17, 1996                        
              Rössling et al. (Rössling)                 5,723,146                    Mar. 3, 1998                         
              Mezei et al. (Mezei), “Liposomes - A Selective Drug Delivery System for the Topical                          
              Route of Administration, Life Science, Vol. 26, pp. 1473-1477 (1980)                                         
              Juliano et al. (Juliano), “Liposomes as a Drug Delivery System for Antisense                                 
              Oligonucleotides,” Antisense Research and Development, Vol. 2, pp. 165-176 (1992)                            
              du Plessis et al. (du Plessis), “Topical Delivery of Liposomally Encapsulated Gamma-                         
              Interferon,” Antiviral Research, Vol. 18, pp. 259-265 (1992)                                                 
                     Claims 116-127 stand rejected under 35 U.S.C. § 103 as unpatentable over                              
              Bonte, Rössling, du Plessis and Mezei; the claims also stand rejected as unpatentable                        
              over Bonte, Rössling, du Plessis, Mezei, Roy and Juliano.                                                    
                     We reverse both of these rejections.                                                                  
                                                     DISCUSSION                                                            
                     The examiner has rejected claims 116-127 as obvious over the combined                                 
              teachings of Bonte, Rössling, du Plessis and Mezei, and also over the combined                               
              teachings of Bonte, Rössling, du Plessis, Mezei, Roy and Juliano.  As the examiner’s                         
              proposed combination of Bonte, Rössling, du Plessis and Mezei is central to both                             
              rejections, we will discuss the two rejections together; as Roy and Juliano are directed                     




Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007